Safety and Tolerability of Conversion to Siponimod With and Without Titration in Patients with Advancing Forms of Relapsing Multiple Sclerosis: Interim Results of the Phase 3b EXCHANGE Study

This publication has no relations, dolmen is empty

Category Primary study
JournalNeurology
Year 2022
This article has no abstract
Epistemonikos ID: 5b56cb1fd34efc165a02274b4c140bc55c27a2b0
First added on: Feb 14, 2025